Steven Pavletic
Dr. Pavletic is a an expert in chronic graft-versus-host disease (cGVHD); his clinical studies focus on improving treatment for patients with cGVHD. Dr. Pavletic has led national and international efforts to develop consensus guidelines for cGVHD clinical trials. Currently, he directs the NIH cGVHD Study Group and the NIH Myeloid Malignancies Clinical Program, which is investigating myelodysplastic syndromes (MDS) and secondary or therapy-related acute myelogenous leukemia (AML).
